The TAXUS stent systems were also used in more than 12 forward looking statements in post-approval registries, in addition to three million TAXUS stents and internationally. – We are pleased that the innovative technology of the TAXUS Express2 stent is now available to physicians in Japan, offering them another treatment option with proven outcomes in a wide range of patients, said Dr. William Hunter, President and CEO Angiotech. – Note on Forward-Looking Statements:. , trademarks of Boston Scientific Corporation Angiotech Pharmaceuticals Angiotech Pharmaceuticals.. The TAXUS stent systems have been tested by the industry’s most extensive randomized, controlled clinical trial program.
The TAXUS stent systems are currently the leading drug – eluting stents in markets outside of Japan. The number of coronary stents implanted annually in Japan is estimated at 200,000, making it the largest market in the world outside the United States.Microsystems Stamping Image property features a eye-opening introduction to 21st centuries production With a robotics systems. ‘clean room ‘for sterile operations and engaged Research & Development ,, the head office like a like a high-tech the invention Labor as a factory.
At Micro Stamping Image based in Somerset, New Jersey, it is large extent that being invisible in that are to the forming enterprises his edge of of highly competitive world of precision component manufacturing.